MRK Trading Analysis - 11/13/2026 01:19 PM โ€” TRU-SENTIMENT

MRK (Merck & Co. Inc.) at $146.73. True Sentiment Bullish, delta 40-60 call 72% / put 28%, call $772,692 vs put $308,502. RSI 53.3.

TRU-SENTIMENT ยท DeltaNeutral

MRK Trading Analysis - 11/13/2026 01:19 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

MRK (Merck & Co. Inc.) at $146.73. True Sentiment Bullish, delta 40-60 call 72% / put 28%, call $772,692 vs put $308,502. RSI 53.3.

Symbol
MRK
Price
$146.73
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-11-13 13:19:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From TRUE SENTIMENT OPTIONS data (2026-11-13):

Call Volume: $772,692.00 (71.5%) Put Volume: $308,502.00 (28.5%) Total: $1,081,194.00

  • Sentiment flagged Bullish with 71.5% call dollar vol vs 28.5% put.
  • 903 call contracts vs 451 put contracts; 26 call trades vs 17 put trades.
  • Pure directional conviction (delta 40-60 filter) shows bullish near-term expectation.
  • No divergence from technicals; both mildly bullish. Only sentiment source available.
Note: Options flow shows heavy call buying at delta 40-60 strikes, supporting upside bias into Dec expiry.

Key Statistics: MRK

$146.69 -0.41%
52-Week Range
$90.90 - $156.92
Market Cap
$361.61B
P/E (TTM)
148.00
PEG Ratio
N/A
Beta
-0.05
Next Earnings
N/A
Avg Volume
$6.45M
Dividend Yield
0.02%

Fundamental Snapshot

Valuation

P/E (trailing)148.00
EPS (trailing 12 mo)$0.99
Market cap$361.61B
Shares outstanding2,465.2M

Dividend

Dividend yield2.31%
Annual dividend$3.40
Ex-dividend date2026-09-15

Risk & range

Beta-0.05
52-week low$90.90
52-week high$156.92
Historical volatility32.4%

Ownership & trading

Institutional ownership54.3%
Average daily volume9.9M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

Recent general-knowledge headlines and context for Merck & Co (MRK) that may frame the current data environment:

  • MRK continues to face pricing and patent-cliff pressure on legacy products, with investor focus on oncology pipeline progress (e.g., Keytruda lifecycle management).
  • Pharmaceutical sector volatility tied to U.S. drug-price negotiation headlines and FDA regulatory updates has remained elevated into late 2026.
  • No confirmed near-term earnings date in the embedded data, but ex-dividend date of 2026-09-15 and stable dividend rate of $3.40 suggest income-focused holding behavior.
  • Broader defensive-pharma rotation may explain negative beta (-0.05) versus market and recent range-bound trade between $138.80 and $154.02.
  • News context is separate from the strict data analysis below, which is derived only from embedded JSON files.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for MRK:

  • Trailing P/E is 148.00 with trailing EPS of 0.99, indicating a rich multiple relative to earnings power.
  • Market capitalization is $361,614,609,510.00 with shares outstanding of 2,465,246,000.00.
  • Dividend yield is 2.31% with dividend rate of $3.40 and ex-dividend date 2026-09-15.
  • Beta is -0.05, showing near-zero correlation to broad market moves (defensive profile).
  • 52-week high is $156.92 and 52-week low is $90.90; current price near $147.29 sits in upper-mid range.
  • Institutional ownership is 54.31%, average volume 9,885,000.00, historical volatility 32.41%.
  • Forward P/E, PEG, profit margins, ROE, debt/equity, and free cash flow are null โ€” cannot assess growth or leverage from data.
  • Analyst consensus and target price are null; no street projection embedded.
  • Fundamentals show high valuation (P/E 148.00) but stable yield and defensive beta, diverging from mildly bullish technicals and options flow.

Current Market Position

From the embedded MINUTE and DAILY data:

  • Current price per indicators is $147.29 (2026-11-12 close); last minute bar 2026-11-13 12:50 is $146.73.
  • Daily close range over last session: open $148.61, high $149.31, low $146.98, close $147.29, volume 4,409,035.
  • Minute bars show opening 2026-11-12 at $148.61 then drift down to $146.73 by 2026-11-13 midday; low intraday $146.58.
  • Intraday momentum is slightly negative but stabilizing near $146.50โ€“$146.73 in late bars.
Support
$146.98
Resistance
$149.31
20-day SMA
$146.40
30d High
$154.02
30d Low
$138.80

Technical Analysis

Technical Indicators

Current Price
$147.29
SMA 5
$147.42
SMA 20
$146.40
SMA 50
$146.25
RSI 14
53.26
MACD
0.49
Signal
0.39
Hist
0.10
BB Mid
$146.40
BB Up
$152.02
BB Low
$140.77
ATR 14
$4.49
  • SMA alignment: SMA 5 ($147.42) > SMA 20 ($146.40) > SMA 50 ($146.25) โ€” mild bullish stack, price above all.
  • RSI 53.26 = neutral-to-slightly bullish momentum, no overbought/oversold.
  • MACD 0.49 above signal 0.39, histogram +0.10 = weak positive momentum.
  • Bollinger mid $146.40, price $147.29 sits just above mid, below upper $152.02 โ€” room to expand.
  • 30-day range high $154.02, low $138.80; price at ~57% of range.

True Sentiment Analysis (Delta 40-60 Options)

From TRUE SENTIMENT OPTIONS data (2026-11-13):

Call Volume: $772,692.00 (71.5%) Put Volume: $308,502.00 (28.5%) Total: $1,081,194.00

  • Sentiment flagged Bullish with 71.5% call dollar vol vs 28.5% put.
  • 903 call contracts vs 451 put contracts; 26 call trades vs 17 put trades.
  • Pure directional conviction (delta 40-60 filter) shows bullish near-term expectation.
  • No divergence from technicals; both mildly bullish. Only sentiment source available.
Note: Options flow shows heavy call buying at delta 40-60 strikes, supporting upside bias into Dec expiry.

Key Price Levels (Observational Only)

Support (SMA50)
$146.25
BB Lower
$140.77
Daily High
$149.31
BB Upper
$152.02
30d High
$154.02

Interactive charts load with JavaScript. This text is the crawlable summary.